Search Results 1591-1600 of 17599 for Absence

  1. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    ... absence of other renal cell carcinoma subtype or urothelial carcinoma);; Bone only urothelial carcinoma or other non-prostate GU tumor;; Urethra carcinoma ...

  2. Study of E7386 in Participants With Selected Advanced Neoplasms - Mayo Clinic

    (INR) ≤ 1.5 (in the absence of therapeutic anticoagulation); - Normal serum calcium and potassium levels as per local laboratory reference ranges; - Serum ...

  3. Publications - Thomas G. Allison, Ph.D., M.P.H. - Mayo Clinic

    ... Absence of Cardiovascular Disease. J Am Heart Assoc. 2020 Oct 20; 9 (19):e017430 Epub 2020 Sept 14. View PubMed; Kelly KL, Carlson AR, Allison TG, Johnson BD ...

  4. Publications - Megan N. Wasson, D.O. - Mayo Clinic

    Congenital Absence of Fallopian Tubes With Malpositioned Ovary Seen at Time of Endometriosis Surgery. J Minim Invasive Gynecol. 2024 Jun; 31 (6):470-471 ...

  5. A Study of Entrectinib (RXDX-101) for the Treatment of Patients with Solid Tumors that have NTRK1/2/3, ROS1, or ALK Gene Rearrangements - Mayo Clinic

    Patients with past HBV infection or resolved HBV infection (defined as the presence of hepatitis B core antibody [HBcAb] and absence of HBsAg) if they are ...

  6. Ethinyl estradiol and norgestrel (oral route) - Side effects & dosage - Mayo Clinic

    Absent, missed, or irregular menstrual periods; backache; belching; bleeding between periods; blurred vision; breast tenderness, pain, enlargement, or secretion ...

  7. Oncology (Medical) - Clinical trials - Mayo Clinic

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  8. Publications - Aoife M. Egan, M.B., B.Ch., Ph.D. - Mayo Clinic

    Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018. J ...

  9. Publications - Naveen L. Pereira, M.D. - Mayo Clinic

    ... Absence of Coronary Artery Disease: Clinical Characteristics and Outcomes. J Am Soc Echocardiogr. 2024 Nov 28 [Epub ahead of print] View PubMed; Angiolillo ...

  10. A Phase 1 Trial of MK-4280 as Monotherapy and in Combination with Pembrolizumab with or without Chemotherapy or Lenvatinib (E7080/MK 7902) in Subjects with Advanced Solid Tumors - Mayo Clinic

    The initial evidence of PD is to be confirmed by a second assessment, no less than 4 weeks from the date of the first documented PD, in the absence of rapid ...